Itron, Inc. (NASDAQ:ITRI) Receives Average Rating of “Moderate Buy” from Analysts

Itron, Inc. (NASDAQ:ITRI) has been assigned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $131.2222.

Several brokerages recently issued reports on ITRI. JPMorgan Chase & Co. cut their price target on Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Stephens reiterated an “overweight” rating and issued a $130.00 price target on shares of Itron in a research note on Wednesday, May 20th. Zacks Research upgraded Itron from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 26th. Guggenheim set a $155.00 target price on Itron in a research note on Friday, February 13th. Finally, Robert W. Baird set a $128.00 target price on Itron and gave the company an “outperform” rating in a research report on Wednesday, February 18th.

Itron Trading Down 2.2%

Shares of ITRI stock opened at $82.12 on Thursday. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97. The stock has a market cap of $3.64 billion, a P/E ratio of 13.10, a price-to-earnings-growth ratio of 0.74 and a beta of 1.33. The stock has a 50 day simple moving average of $87.17 and a 200 day simple moving average of $93.28. Itron has a 1 year low of $77.77 and a 1 year high of $142.00.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.23. The business had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.The firm’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, research analysts predict that Itron will post 6.01 earnings per share for the current fiscal year.

Insider Activity

In other news, SVP John F. Marcolini sold 322 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $27,167.14. Following the completion of the transaction, the senior vice president directly owned 24,689 shares in the company, valued at approximately $2,083,010.93. This represents a 1.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Joan S. Hooper sold 442 shares of the stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $37,291.54. Following the completion of the transaction, the chief financial officer owned 117,478 shares of the company’s stock, valued at $9,911,618.86. The trade was a 0.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 3,946 shares of company stock worth $324,420. Insiders own 1.77% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC raised its position in Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after purchasing an additional 81 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after purchasing an additional 101 shares during the last quarter. Xponance Inc. grew its holdings in Itron by 3.2% during the 3rd quarter. Xponance Inc. now owns 3,757 shares of the scientific and technical instruments company’s stock worth $468,000 after acquiring an additional 115 shares during the period. Impact Partnership Wealth LLC raised its position in shares of Itron by 4.7% in the 1st quarter. Impact Partnership Wealth LLC now owns 2,661 shares of the scientific and technical instruments company’s stock worth $239,000 after acquiring an additional 119 shares in the last quarter. Finally, Xponance LLC lifted its stake in shares of Itron by 3.2% in the 4th quarter. Xponance LLC now owns 3,877 shares of the scientific and technical instruments company’s stock valued at $360,000 after purchasing an additional 120 shares during the period. 96.19% of the stock is currently owned by institutional investors.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.